In AD and mild cognitive impairment, melatonin given alongside cholinesterase inhibitors such as donepezil improved cognitive performance, sleep quality, and reduced depressive symptoms, supporting its use as an adjunctive chronotherapeutic agent [165]. The gene discussed is BCHE; the disease is Alzheimer disease.